Skip to content
After more than 30 years since he was diagnosed with HIV, a 66-year-old patient is in full remission after receiving a stem cell transplant […]
66-year-old HIV patient cured by stem cell transplant Read More »
According to new research published today by Vital Transformation, if drug price controls under consideration in the Senate had been in place over the
Drug price controls will destroy drug development, says study Read More »
Today is World Hepatitis Day. With a person dying every 30 seconds from a hepatitis-related illness, according to the World Hepatitis Alliance, viral hepatitis
World Hepatitis Day: Can we eliminate hepatitis? Read More »
In a move to fight genetic high cholesterol, which can be fatal, biotech companies are deploying siRNA and antisense oligonucleotides, according to a new
Biotech companies develop drugs to fight genetic high cholesterol Read More »
Growing vegetables in space is no longer sci-fi, but rather fully possible, according to The Conversation. As climate change is affecting our capacity to
Biotech can help us grow veggies in space Read More »
This week, the House of Representatives might vote on a plan to prolong telehealth reimbursement flexibilities until 2024. On Tuesday, the House Rules Committee
Legislators propose prolonging telehealth flexibility until end of 2024 Read More »
Chinese scientists have discovered a method for increasing rice crop productivity by up to 40% by altering the plant’s genetic material, by adding a
Biotech helped scientists ‘supercharge’ rice productivity Read More »
The leading horizontal platform for cell programming, Ginkgo Bioworks, announced on Tuesday it has inked agreements to acquire two teams and technologies that would
Ginkgo Bioworks acquires Zymergen, Bayer’s R&D site Read More »
Gevo, Inc. revealed a new sales deal with American Airlines, Inc, the company announced. Gevo will sell 100 million gallons of sustainable aviation fuel
Gevo SAF deal with American Airlines expected to bring in $2.75 billion Read More »
Bristol-Myers Squibb (BMS) has created the Disability Diversity in Clinical Trials (DDiCT) program to promote fair access to clinical trials and to ensure that
Bristol Myers Squibb launches program to promote disability diversity in clinical trials Read More »
